Charleston Drug Recall Lawyers
Meridia (sibutramine) is a prescription weight loss drug marketed and sold in the United States by Abbot Laboratories. Meridia was approved in November 1997 for weight loss and weight management. A recent study indicates an increased risk of heart attack and stroke in Meridia users. The study showed a sixteen percent (16%) increase in the risk of non-fatal heart attacks and non-fatal strokes. On October 8, 2010, based upon this study, Abbot issued a recall of this medication. The recall comes on the heels of a major label change earlier this year, which set forth the following warnings:
Meridia is not to be used in patients with a history of cardiovascular disease, including:
- History of coronary artery disease (e.g., heart attack, angina)
- History of stroke or transient ischemic attack (TIA)
- History of heart arrhythmias
- History of congestive heart failure
- History of peripheral arterial disease
- Uncontrolled hypertension (e.g., > 145/90 mmHg)
Serious Side-Effects
If you or a loved one have taken Meridia and suffered from a heart attack, stroke or other serious injury you may be entitled to compensation.
CONTACT US
Our attorneys are here to help you obtain compensation for your injuries. Please contact us today for a Free evaluation by calling James F. Humphreys & Associates, L.C. 1-877-341-2595.
